After years of feeling unwell and overweight, Richard and Jill Wendt decided to embark on a weight loss journey together and ...
The Centers for Medicare & Medicaid Services has proposed a rule expanding Medicare and Medicaid patients’ access to anti-obesity drugs such as GLP-1s.
The Washington Post on MSN6d
FDA approves weight-loss drug Zepbound to treat sleep apneaThe Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...
TV star and comedian Katherine Ryan has responded to claims from her teenage daughter that she has been using controversial ...
Ozempic, Wegovy and Mounjaro, all GLP-1 anti-obesity medications, may offer health benefits beyond weight loss. Studies show ...
The mother-of-three hit back at eldest child Violet, 14, after the teenager convinced herself that her mother was on Ozempic.
Eli Lilly will seek to have Mounjaro listed on the scheme this year. If successful, it would mean taxpayer subsidies for the ...
Axios on MSN3d
Use of diabetes and anti-obesity drugs surges nationwideAxios Visuals The number of prescriptions for GLP-1 drugs jumped roughly 10% in 2024, according to insurance claims data provided to Axios by health analytics company PurpleLab. Why it matters: The ...
Below are some of the conditions that anti-obesity medications may help improve: GLP-1 medications seem to be good for the heart. Medicare announced that it will cover semaglutide medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback